From: Developing preclinical models of neuroblastoma: driving therapeutic testing
PDX Line | Stage of Tumor | Age of Patient (Yr.M) | MCYN Status | p53 Status | Organization |
---|---|---|---|---|---|
NB-SD | 4 | 1 | Amp | Mut | Pediatric Preclinical Testing Program |
NB-1771 | 4 | 2.1 | Amp | Mut | |
NB-1691 | 4 | 1.9 | Amp | WT | |
NB-EBc1 | 4 | 2.6 | Non Amp | WT | |
CHLA-79 | 4 | 2 | Non Amp | WT | |
NB-1643 | 4 | 1.7 | Amp | WT | |
NB-1382 | 3 | 3.5 | Amp | N/A | |
IGR-NB8 | 3 | 5.0 | Amp | N/A | Insitut Curie |
IGR-N835 | 4 | 2.0 | Amp | N/A | |
MAP-IC-A23-NB-1 | L2 | 2.6 | Non Amp | N/A | |
MAP-GR-B25-NB-1 | 4 | 4.0 | Amp | N/A | |
MAP-GR-A99-NB-1 | 4 | 1.10 | Amp | N/A | |
HSJD-NB-011 | 4 | 2.6 | Amp | N/A | |
SJNBL012407_X1 | 4 | 0.1 | Amp | N/A | Children’s Solid Tumor Network |
SJNBL013761_X1 | 4 | 3.0 | Non Amp | N/A | |
SJNBL013762_X1 | 4 | 1.3 | Amp | N/A | |
SJNBL013763_X1 | 2B | 2.0 | Amp | N/A | |
SJNBL015724_X1 | 4 | 2.0 | Non Amp | N/A | |
SJNBL046_X | 4 | 2.0 | Amp | N/A | |
SJNBL108_X | 4 | 3.0 | Non Amp | N/A | |
SJNBL046145_X1 | 4 | 2.0 | Non Amp | N/A | |
SJNBL046148_X1 | 4 | 1.11 | Amp | N/A | |
SJNBL047443_X1 | 4 | 12.0 | Non Amp | N/A | |
PDX-1 | 4 | 1.4 | Amp | N/A | Lund University |
PDX-2 | 4 | 2.2 | Amp | N/A | |
PDX-3 | 3 | 2.9 | Amp | N/A | |
PDX-4 | 4 | 4.9 | Amp | N/A | |
PDX-5 | 4 | 2.4 | Non Amp | N/A | |
PDX-6 | 2B | 12.0 | Amp | N/A | |
COG-N-415x | Unknown | Unknown | Amp | WT | Children’s Oncology Group |
COG-N-440x | Unknown | Unknown | Amp | WT | |
COG-N-453x | Unknown | Unknown | Amp | WT | |
COG-N-471x | Unknown | Unknown | Amp | WT | |
COG-N-496x | Unknown | Unknown | Amp | N/A | |
COG-N-519x | Unknown | Unknown | Amp | N/A | |
COG-N-534 m | Unknown | Unknown | Non Amp | N/A | |
COG-N-549x | Unknown | Unknown | Non Amp | N/A | |
COG-N-557x | Unknown | Unknown | Amp | N/A | |
COG-N-573x | Unknown | Unknown | Amp | N/A | |
Felix (COG-N-426) | Unknown | Unknown | Non Amp | N/A | |
CHLA-90 | 4 | 8 | Non Amp | N/A | |
CHLA-136 | 4 | 3 | Amp | N/A |